34 Works
Additional file 1 of Parvimonas micra activates the Ras/ERK/c-Fos pathway by upregulating miR-218-5p to promote colorectal cancer progression
Yuxiao Chang, Ziran Huang, Fengyi Hou, Yuejiao Liu, Likun Wang, Zhen Wang, Yifan Sun, Zhiyuan Pan, Yafang Tan, Lei Ding, Hong Gao, Ruifu Yang & Yujing Bi
Additional file 1.
Additional file 1 of EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, Jana Barinoff, Volkmar Müller, Jens-Uwe Blohmer, Christian Schem, Knut Engels, Frederik Marmé, Annette Fisseler-Eckhoff, Peter A. Fasching, Elmar Stickeler, Marion van Mackelenbergh, Carsten Denkert, Albrecht Stenzinger, Sibylle Loibl & Stefan Gröschel
Additional file 1: Supplementary Figure 1. Flow diagram of patients included in the analysis set from GeparTrio study.
Additional file 2 of EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, Jana Barinoff, Volkmar Müller, Jens-Uwe Blohmer, Christian Schem, Knut Engels, Frederik Marmé, Annette Fisseler-Eckhoff, Peter A. Fasching, Elmar Stickeler, Marion van Mackelenbergh, Carsten Denkert, Albrecht Stenzinger, Sibylle Loibl & Stefan Gröschel
Additional file 2: Supplementary Figure 2. Distribution of EVI1 continuous expression in breast cancer: A: Histogram of EVI1 continuous expression in the entire cohort (N=993); B: Boxplots of EVI1 continuous expression within breast cancer subtypes. Note, 882/993 patients with available BC subtype information were included in this analysis. Horizontal bold lines present EVI1 median values of 116.65 in HR+/HER2-, 98.67 in HR+/HER2+, 114.77in HR-/HER2+, and 115.64 in TNBC; boxes present the interquartile range between first...
Additional file 1 of Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards
Damian T. Rieke, Till de Bortoli, Peter Horak, Mario Lamping, Manuela Benary, Ivan Jelas, Gina Rüter, Johannes Berger, Marit Zettwitz, Niklas Kagelmann, Andreas Kind, Falk Fabian, Dieter Beule, Hanno Glimm, Benedikt Brors, Albrecht Stenzinger, Stefan Fröhling & Ulrich Keilholz
Additional file 1: Figure S1. Shows the respective molecular tumor board workflows of Heidelberg (HDB) and Berlin (BLN). Corresponding steps are indicated by their respective colors.
Additional file 3 of EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, Jana Barinoff, Volkmar Müller, Jens-Uwe Blohmer, Christian Schem, Knut Engels, Frederik Marmé, Annette Fisseler-Eckhoff, Peter A. Fasching, Elmar Stickeler, Marion van Mackelenbergh, Carsten Denkert, Albrecht Stenzinger, Sibylle Loibl & Stefan Gröschel
Additional file 3: Supplementary Figure 3. Kaplan-Meier estimates of DFS (A) and OS (B) according to EVI1 expression in the non-pCR subgroup. Abbreviations:pCR, pathological complete response; DFS, disease-free survival; OS, overallsurvival.
Additional file 1 of Lung-gut axis of microbiome alterations following co-exposure to ultrafine carbon black and ozone
Md Habibul Hasan Mazumder, Jasleen Gandhi, Nairrita Majumder, Lei Wang, Robert Ian Cumming, Sydney Stradtman, Murugesan Velayutham, Quincy A. Hathaway, Jonathan Shannahan, Gangqing Hu, Timothy R. Nurkiewicz, Robert M. Tighe, Eric E. Kelley & Salik Hussain
Additional file 1. Sequence data are available in NCBI database BioProject PRJNA891236. The online version contains additional file available at journal website. It includes. Figure S1: Changes in weight after single and multiple CB, O3 and CB + O3 inhalation exposures. Figure S2: Gating strategy for identifying inflammatory cells in lungs. A Flow gating strategy to detect cell types in lungs after air, CB, O3 or CB + O3 exposure either for 3 h for...
Additional file 1 of Lung-gut axis of microbiome alterations following co-exposure to ultrafine carbon black and ozone
Md Habibul Hasan Mazumder, Jasleen Gandhi, Nairrita Majumder, Lei Wang, Robert Ian Cumming, Sydney Stradtman, Murugesan Velayutham, Quincy A. Hathaway, Jonathan Shannahan, Gangqing Hu, Timothy R. Nurkiewicz, Robert M. Tighe, Eric E. Kelley & Salik Hussain
Additional file 1. Sequence data are available in NCBI database BioProject PRJNA891236. The online version contains additional file available at journal website. It includes. Figure S1: Changes in weight after single and multiple CB, O3 and CB + O3 inhalation exposures. Figure S2: Gating strategy for identifying inflammatory cells in lungs. A Flow gating strategy to detect cell types in lungs after air, CB, O3 or CB + O3 exposure either for 3 h for...
Additional file 2 of EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, Jana Barinoff, Volkmar Müller, Jens-Uwe Blohmer, Christian Schem, Knut Engels, Frederik Marmé, Annette Fisseler-Eckhoff, Peter A. Fasching, Elmar Stickeler, Marion van Mackelenbergh, Carsten Denkert, Albrecht Stenzinger, Sibylle Loibl & Stefan Gröschel
Additional file 2: Supplementary Figure 2. Distribution of EVI1 continuous expression in breast cancer: A: Histogram of EVI1 continuous expression in the entire cohort (N=993); B: Boxplots of EVI1 continuous expression within breast cancer subtypes. Note, 882/993 patients with available BC subtype information were included in this analysis. Horizontal bold lines present EVI1 median values of 116.65 in HR+/HER2-, 98.67 in HR+/HER2+, 114.77in HR-/HER2+, and 115.64 in TNBC; boxes present the interquartile range between first...
Additional file 1 of Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards
Damian T. Rieke, Till de Bortoli, Peter Horak, Mario Lamping, Manuela Benary, Ivan Jelas, Gina Rüter, Johannes Berger, Marit Zettwitz, Niklas Kagelmann, Andreas Kind, Falk Fabian, Dieter Beule, Hanno Glimm, Benedikt Brors, Albrecht Stenzinger, Stefan Fröhling & Ulrich Keilholz
Additional file 1: Figure S1. Shows the respective molecular tumor board workflows of Heidelberg (HDB) and Berlin (BLN). Corresponding steps are indicated by their respective colors.
Visualization S2.mp4
Lei Wang
macroscopic laser pulling of the CLG-SiO2 sample with wavelength of 488 nm and laser power of 85 mW at the air pressure of 5 Pa
Visualization S3.mp4
Lei Wang
macroscopic laser pulling of the CLG-SiO2 sample with wavelength of 360 nm and laser power of 13 mW at the air pressure of 5 Pa
Visualization S5.mp4
Lei Wang
macroscopic laser pulling of the CLG-SiO2 sample with wavelength of 488 nm and laser power of 17 mW at the air pressure of 5 Pa
Visualization S2.mp4
Lei Wang
macroscopic laser pulling of the CLG-SiO2 sample with wavelength of 488 nm and laser power of 85 mW at the air pressure of 5 Pa
Visualization S3.mp4
Lei Wang
macroscopic laser pulling of the CLG-SiO2 sample with wavelength of 360 nm and laser power of 13 mW at the air pressure of 5 Pa
Visualization S4.mp4
Lei Wang
laser irradiation of the CLG-SiO2 sample with wavelength of 532 nm and laser power of 60 mW at normal pressure
Visualization S5.mp4
Lei Wang
macroscopic laser pulling of the CLG-SiO2 sample with wavelength of 488 nm and laser power of 17 mW at the air pressure of 5 Pa
Visualization S6.mp4
Lei Wang
macroscopic laser pulling of the CLG-SiO2 sample with wavelength of 488 nm and laser power of 34 mW at the air pressure of 5 Pa
Visualization S7.mp4
Lei Wang
macroscopic laser pulling of the CLG-SiO2 sample with wavelength of 488 nm and laser power of 51 mW at the air pressure of 5 Pa
Additional file 1 of Parvimonas micra activates the Ras/ERK/c-Fos pathway by upregulating miR-218-5p to promote colorectal cancer progression
Yuxiao Chang, Ziran Huang, Fengyi Hou, Yuejiao Liu, Likun Wang, Zhen Wang, Yifan Sun, Zhiyuan Pan, Yafang Tan, Lei Ding, Hong Gao, Ruifu Yang & Yujing Bi
Additional file 1.
Visualization S1.mp4
Lei Wang
macroscopic laser pulling of the CLG-SiO2 sample with wavelength of 532 nm and laser power of 60 mW at the air pressure of 5 Pa
Visualization S6.mp4
Lei Wang
macroscopic laser pulling of the CLG-SiO2 sample with wavelength of 488 nm and laser power of 34 mW at the air pressure of 5 Pa
Visualization S7.mp4
Lei Wang
macroscopic laser pulling of the CLG-SiO2 sample with wavelength of 488 nm and laser power of 51 mW at the air pressure of 5 Pa
Visualization S1.mp4
Lei Wang
macroscopic laser pulling of the CLG-SiO2 sample with wavelength of 532 nm and laser power of 60 mW at the air pressure of 5 Pa
sj-pptx-3-eso-10.1177_23969873221143856 – Supplemental material for Ability of patients with acute ischemic stroke to recall given information on intravenous thrombolysis: Results of a prospective multicenter study
Luzie Schuster, Fabian Essig, Naeimeh Daneshkhah, Juliane Herm, Simon Hellwig, Matthias Endres, Ulrich Dirnagl, Frank Hoffmann, Dominik Michalski, Waltraud Pfeilschifter, Christian Urbanek, Gabor C Petzold, Timolaos Rizos, Andrea Kraft & Karl Georg Haeusler
Supplemental material, sj-pptx-3-eso-10.1177_23969873221143856 for Ability of patients with acute ischemic stroke to recall given information on intravenous thrombolysis: Results of a prospective multicenter study by Luzie Schuster, Fabian Essig, Naeimeh Daneshkhah, Juliane Herm, Simon Hellwig, Matthias Endres, Ulrich Dirnagl, Frank Hoffmann, Dominik Michalski, Waltraud Pfeilschifter, Christian Urbanek, Gabor C Petzold, Timolaos Rizos, Andrea Kraft and Karl Georg Haeusler in European Stroke Journal
Additional file 1 of EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, Jana Barinoff, Volkmar Müller, Jens-Uwe Blohmer, Christian Schem, Knut Engels, Frederik Marmé, Annette Fisseler-Eckhoff, Peter A. Fasching, Elmar Stickeler, Marion van Mackelenbergh, Carsten Denkert, Albrecht Stenzinger, Sibylle Loibl & Stefan Gröschel
Additional file 1: Supplementary Figure 1. Flow diagram of patients included in the analysis set from GeparTrio study.